Chelsea to Conduct Further Trial to Show Effectiveness of Northera

Chelsea to Conduct Further Trial to Show Effectiveness of Northera

It has been reported that the Food and Drug Administration of the US has asked the manufacturer of Northera, a low-blood-pressure medication to provide with more proves to show that the medication is effective in treating low-blood-pressure.

Following the revelation, the shares of Chelsea Therapeutics International Ltd. (CHTP) fell down significantly. The Food and Drug Administration has expressed doubts over the benefits of the medication.

Last month, the advisory committee of the Food and Drug Administration voted against the medication. Since then, the manufacturer has been in talks with the authorities. It has been informed that the controversial drug, Northera, is already being sold in Japan for past 20 years.

The Food and Drug Administration has said that the drug taken by patients for weeks doesn’t leaves effective effect on the patient health. The manufacturer has informed that the drug is capable of controlling the problem of low-blood-pressure for two or three months.

The Food and Drug Administration have also recommended of labeling on the medication package. The labeling, as recommended by the administration, should clearly highlight that a patient taking the drug would experience dizziness and lightheadedness.

Chelsea said that it would be working as per the guidelines of the authorities. The company has estimated that within five years of its sales, the firm can book revenue of 300 million to $375 million. However, it is yet not clear as to when the drug would be launched.

The company would be conducting yet another trial to show the effectiveness of the drug in treating low-blood-pressure. It has been informed that the drug has an orphan status. It means that the drug has the potential of treating a rare type of health problem which affects 200,000 Americans.


FrenchTribune Specials

Three Tiny Polar Bear Triplets born in Ouwehands Zoo

Polar bear triplets have been born in a Dutch zoo and both mother and babies are all in good health.

According to Head keeper at Ouwehands Zoo, Dirk Jan van der Kolk, zoo staff is positive for the cubs' survival through the winter.

"At this moment they look very healthy, they are drinking from their mother, they are very active...

Most Popular

Bonsoy to pay $25 million to those 'poisoned' by soy milk

Bonsoy, a leading soy milk brand, has said that it has...

Time magazine includes Mangalyaan among best inventions of 2014

Time magazine has announced the list of best inventions...

Tiger Sharks Tracked to find out Its Movements

Many myths will be cleared with a new study based on the...

An Ancient Egyptian handbook on Spells Deciphered

The secret of the ancient Egyptian invocations and...

Poll

Can Greece Come out of Economic Problems: